Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Inarigivir soproxil (SB9200) is an agonist of innate immunity. It also displays effective antiviral activity against resistant hepatitis C virus (HCV) variants (EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 42,000 | |||
5 mg | 在庫あり | ¥ 91,000 | |||
10 mg | 在庫あり | ¥ 135,500 | |||
25 mg | 在庫あり | ¥ 217,000 | |||
50 mg | 在庫あり | ¥ 294,000 | |||
100 mg | 在庫あり | ¥ 397,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 144,500 |
説明 | Inarigivir soproxil (SB9200) is an agonist of innate immunity. It also displays effective antiviral activity against resistant hepatitis C virus (HCV) variants (EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems). |
ターゲット&IC50 | HCV 1a/1b:(EC50)2.2/1.0 μM |
In vitro | Inarigivir soproxil is shown to inhibit HCV replication and the range of inhibition is comparable between genotypes 1a and 1b. Inarigivir soproxil is an oral modulator of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil demonstrates pan-genotypic antiviral activity against HCV. Inarigivir soproxil is active against DAA-resistant HCV variants. SB 9200 has broad-spectrum antiviral activity against RNA viruses including hepatitis C virus (HCV), norovirus, respiratory syncytial virus and influenza and has demonstrated activity against hepatitis B virus (HBV)[1]. |
別名 | SB9200 |
分子量 | 703.62 |
分子式 | C25H34N7O13PS |
CAS No. | 942123-43-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 102 mg/mL (144.96 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Inarigivir soproxil 942123-43-5 Microbiology/Virology Proteases/Proteasome HCV Protease inhibit Inhibitor HCV replicon GS-9992 GS9992 antiviral activity against HCV Hepatitis C virus innate immunity SB9200 GS 9992 SB-9200 HBV Hepatitis B virus SB 9200 inhibitor